β-glucans (Dectin-1 agonist) exhibited antitumor activities in several mouse tumor models (86) by reprograming tumor-infiltrating DCs to secrete IL-12p70 favoring Th1 response (87). The gene discussed is CLEC7A; the disease is neoplasm.